Medtronic received European approval and is launching the new Evera MRI SureScan implantable cardioverter-defibrillator (ICD) on the continent. This is the world’s first ICD approved to be compatible during MRI scanning of any part of the patient’s anatomy.
The device has an estimated 11 year battery life and uses Medtronic’s Sprint Quattro Secure MRI-compatible leads. It features the company’s SmartShock 2.0 technology that prevents inappropriate shocks caused by electrical noise and arrhythmias not warranting a correction. The device also includes reporting capabilities on the patient cardiac status and notes any potential cases of atrial fibrillation.